All News #Library
Sciences
Trevi Therapeutics Announces License Agreements for use of Nalbuphine
04 Feb 2019 //
BUSINESSWIRE
Trevi Therapeutics Initiates Clinical Trial of Nalbuphine in Prurigo Nodularis
27 Sep 2018 //
BUSINESSWIRE

Market Place
Sourcing Support